Search clinical trials for: Parkinson's disease (PD)

Total 385683 results

Cairo University

Not yet recruiting

Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study

Lichen Planus

Egypt
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Pembrolizumab (MK-3475) in Chinese Participants With Locally Advanced or Metastatic Melanoma (MK-3475-151/KEYNOTE-151)

Melanoma
Merck Sharp & Dohme LLC

Active, not recruiting

A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

Hodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
Merck Sharp & Dohme LLC

Completed

A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)

Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Primary Mediastinal B-Cell Lymphoma
Merck Sharp & Dohme LLC

Terminated

A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)

Multiple Myeloma
Maastricht Radiation Oncology

Completed

Immune Profiling After HDR in Local Relapsed Prostate Cancer (PRIMUS)

Prostate Cancer | PD-L1

Netherlands
Duke University
Merck Sharp & Dohme LLC; Ipsen

Completed

Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)

Gastroenteropancreatic Neuroendocrine Tumors

United States
Instituto Nacional de Cancerologia de Mexico

Unknown

Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients

Non-Small Cell Lung Cancer

Mexico
AZ Sint-Jan AV
Paul Tulkens, Louvain drug research institute, belgium; Francoise Van Bambeke... and other collaborators

Completed

Temocillin Pharmacokinetic in Hemodialysis

Gram-Negative Bacterial Infections | Renal Failure Chronic Requiring Hemodialysis

Belgium
University of Alabama at Birmingham

Completed

Diagnosis of PD and PD Progression Using DWI (K23)

Parkinson's Disease

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm

United States
Altec Inc.
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

A Smartphone Application for Neurology and Telemedicine (NeuroVision)

Parkinson Disease(PD)

United States
Beijing Tiantan Hospital

Recruiting

EC50 of Dexmedetomidine in Deep Brain Stimulation Implantation of Patients With Parkinson's Disease

PD - Parkinson's Disease

China
Boston Scientific Corporation

Recruiting

Coordinated Reset Deep Brain Stimulation (RESET-DBS)

Parkinson's Disease (PD)

Germany
AbbVie

Active, not recruiting

Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease

Parkinson's Disease (PD)

United States, Australia
AbbVie

Completed

Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

Parkinson's Disease (PD)

United States, Australia
Bial - Portela C S.A.

Completed

Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Parkinson's Disease (PD)

Portugal
Bial - Portela C S.A.

Completed

An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites

Parkinson's Disease (PD)

Netherlands
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa

Parkinson's Disease (PD)

Canada
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC (HNC-SYSU-002)

Oral Cancer | HNSCC | PD-1

China
Sun Yat-sen University

Recruiting

G-CSF in Patients With Anti-PD-1-axis Therapy-resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

PD-1 Inhibitor | Granulocyte Colony-Stimulating Factor

China
Tools4Patient

Completed

A Study to Investigate a New Treatment in Patients With Parkinson's Disease

Parkinson Disease

United States, France, Belgium
Shanghai Jiao Tong University School of Medicine

Not yet recruiting

Effect of Pre-emptive Assessment of Self-care Peritoneal Dialysis (PD) Ability on PD Choice in Patients With Stage 5 Chronic Kidney Disease

Chronic Kidney Disease (CKD) Stage 5

China
Biogen

Completed

Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's Disease

Healthy | Parkinson's Disease

United States
Rush University Medical Center
Purdue University; California Institute of Technology

Completed

Targeting Diet-Microbiome Interactions in the Pathogenesis of Parkinson's Disease

Parkinson Disease

United States
Pfizer

Terminated

A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis

Pulmonary Sarcoidosis

United States
Merck Sharp & Dohme LLC

Active, not recruiting

Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)

Renal Cell Carcinoma
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Dietary Adherence Enhancement in Peritoneal Dialysis: BalanceWise-PD (BalanceWise-PD)

End-Stage Renal Disease

United States
PD Dr. med. Katja Hatz

Completed

Comparison of Quantitative Metamorphopsia- Measurements in Patients With mCNV

Metamorphopsia

Switzerland
Prim PD Dr Afshin Assadian
Wilhelminenspital Vienna

Unknown

The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation (ILOFLOW)

Arteriosclerosis | Diabetes | Peripheral Arterial Occlusive Disease | Neuropathy

Austria
PD Dr. Martin Glas

Unknown

Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma (TKI258)

First or Second Recurrence of Glioblastoma

Germany
Prim PD Dr Afshin Assadian
Wilhelminenspital Vienna

Unknown

The Use of Cardiovascular Biomarkers in Abdominal Aortic Surgery (BIAS)

Arterial Occlusive Diseases | Aortic Aneurysm, Abdominal

Austria
Lawson Health Research Institute

Terminated

Percussion Device (PD) for Detection of Pneumothorax

Pneumothorax

Canada
China Medical University, China

Not yet recruiting

Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma

PD-1 Antibody | Gastrointestinal Tumours | DC-Cell | NK-Cell
Mahmoud Ramadan mohamed Elkazzaz

Not yet recruiting

CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients

COVID-19 Respiratory Infection
University of Colorado, Boulder
National Institute of Mental Health (NIMH); Emory University; Kaiser Permanente

Completed

The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression

Depression | Postpartum Depression | Pregnancy

United States
Peking Union Medical College Hospital

Recruiting

Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC

Hepatocellular Carcinoma

China
Istari Oncology, Inc.

Active, not recruiting

LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma

Melanoma

United States
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation

Spain, Italy, Austria, Netherlands, United Kingdom, Thailand, France, Belgium, China, Germany, Greece, Argentina, Turkey, Malaysia, Portugal, Brazil, United States, Hungary, India
Dalian University

Unknown

Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody

Non-small Cell Lung Cancer
Somogy Megyei Kaposi Mór Teaching Hospital
University of Groningen

Completed

Compare the Effects of Agility and Cycling Exercise Training on Mobility and Balance in PD and Healthy Old Adults

Healthy | Parkinson Disease | Movement Disorders | Condition

Hungary
Xuanwu Hospital, Beijing
XINGIMAGING LLC; The Michael J. Fox Foundation for Parkinson's Research; Naming...

Recruiting

AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's Disease

Parkinson Disease

China
GlaxoSmithKline

Completed

Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)

Parkinson Disease

Japan
AbbVie

Recruiting

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease (ROSSINI)

Parkinson's Disease (PD)

Germany, Denmark, Spain, Israel
Beijing Tiantan Hospital

Recruiting

Effects of Propofol on Brain Function in Patients With Parkinson's Disease

PD - Parkinson's Disease

China
AbbVie

Active, not recruiting

Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease

Parkinson's Disease (PD)

United States, Australia, Belgium, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Spain, United Kingdom, Sweden
Federal University of Rio Grande do Sul
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.; University of...

Completed

Effects of Dance on the Turning Characteristics of Patients With Parkinson's Disease

Parkinson Disease(PD)

Brazil, United Kingdom
AbbVie

Completed

Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients

Parkinson Disease (PD)

Canada
Bial - Portela C S.A.

Completed

The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics

Parkinson's Disease (PD)

France
Bial - Portela C S.A.

Completed

Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics

Parkinson's Disease (PD)

France

Search clinical trials for: Parkinson's disease (PD)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations